Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

PureTech Health plc - American Depositary Shares (NQ: PRTC )

18.95 UNCHANGED
Streaming Delayed Price Updated: 3:33 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PureTech Health plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 Next >
PureTech Announces Participation in Two Upcoming Investor Conferences
From PureTech Health plc
Via Business Wire
PureTech Presents Clinical Trial Design Supporting Wholly Owned Immuno-Oncology Candidate LYT-200 at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
From PureTech Health plc
Via Business Wire
PureTech Receives Orphan Drug Designation for Wholly Owned Candidate LYT-200 for the Treatment of Pancreatic Cancer
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China
From PureTech Health plc
Via Business Wire
PureTech Announces Participation at the Jefferies London Healthcare Conference
From PureTech Health plc
Via Business Wire
PureTech Is Pleased to Note Publication in Nature’s Scientific Reports Featuring the Gelesis Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Vedanta Biosciences Appoints Simona Levi as Chief Legal Officer and Corporate Secretary
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Vedanta Announces Positive Topline Phase 2 Data for VE303 in High-Risk C. difficile Infection and Exercise of $23.8 Million Option by BARDA
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Sonde Health Launches Vocal Biomarker Technology to Monitor Mental Health and Well-Being
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Akili Announces Topline Results from Shionogi Phase 2 Study in Japan
From PureTech Health plc
Via Business Wire
PureTech Announces Publication of New Preclinical Research from Collaborators that Supports Mesenteric Lymphatic Dysfunction as a Potential Cause of and Therapeutic Target for Obesity and Insulin Resistance
From PureTech Health plc
Via Business Wire
PureTech to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Vor Biopharma Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid Leukemia
From PureTech Health plc
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Valneva (NASDAQ:VALN) stock moved upwards by 29.61% to $49.9 during Monday's regular session. Valneva's stock is trading at a volume of 143.0K shares as of... 
Via Benzinga
Earnings Scheduled For August 24, 2021
Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is likely to report earnings for its second quarter. • Genetron Holdings (NASDAQ:GTH) is... 
Via Benzinga
PureTech Health plc – Half-Year Report
From PureTech Health plc
Via Business Wire
PureTech Presents Phase 1 Data for LYT-100 at the European Respiratory Society International Congress 2021
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments
From PureTech Health plc
Via Business Wire
PureTech Announces the Appointment Julie Krop, M.D., as Chief Medical Officer
From PureTech Health plc
Via Business Wire
Imbrium Therapeutics To Develop PureTech's Non-Opioid Candidate For Chronic Bladder Condition
Imbrium Therapeutics has exercised a license option to develop PureTech Health plc's (NASDAQ: PRTC) LYT-503/IMB-150 (formerly designated as ALV-107... 
Via Benzinga
PureTech Announces That Imbrium Therapeutics Has Exercised License Option to LYT-503/IMB-150 for Interstitial Cystitis/Bladder Pain Syndrome
From PureTech Health plc
Via Business Wire
PureTech: Notice of Half-Yearly Results
From PureTech Health plc
Via Business Wire
The Week In SPAC News - Sunday, July 25
In SPAC news this week, BBQGuys, PropertyGuru, and Cvent announced merger deals, while Vice Media's plan to go public via a SPAC merger has reportedly stalled. 
Via Talk Markets
PureTech Founded Entity Akili Releases New Gameplay Features in the First and Only FDA-Cleared Video Game Treatment for Children With ADHD
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Vedanta Biosciences Completes $68 Million Series D Financing
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Gelesis, the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp.
From PureTech Health plc
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Nkarta (NASDAQ:NKTX) shares moved upwards by 8.03% to $30.0 during Thursday's regular session. The current volume of 180.7K shares is 71.9% of Nkarta's... 
Via Benzinga
PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)
From PureTech Health plc
Via Business Wire
PureTech Founded Entity Sonde Health Announces Collaboration with Qualcomm Technologies for Use of Vocal Biomarker Technology on Qualcomm Snapdragon Mobile Platforms
From PureTech Health plc
Via Business Wire
PureTech Health To Test LYT-200 / Tislelizumab Combo In Difficult To Treat Cancer
PureTech Health plc (NASDAQ: PRTC) has announced a clinical trial and supply agreement with an affiliate of BeiGene Ltd (NASDAQ: BGNE). The partnership... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.